As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Announcing the launch of In Review
Reproductive Biology and Endocrinology, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
Share their work with fellow researchers to read, comment on, and cite even before publication
Showcase their work to funders and others with a citable DOI while it is still under review
Track their manuscript - including seeing when reviewers are invited, and when reports are received
Aims and scope
Reproductive Biology and Endocrinology publishes and disseminates high-quality results from excellent research in the reproductive sciences.
The journal publishes on topics covering gametogenesis, fertilization, early embryonic development, embryo-uterus interaction, reproductive development, pregnancy, uterine biology, endocrinology of reproduction, control of reproduction, reproductive immunology, neuroendocrinology, and human reproductive medicine.
We accept papers on non-human primates, rats, and mice if they inform the human condition. However, we will no more horses, dogs, sheep, cats, cows, pigs, birds, or fish.
Follow us on Twitter at @RBEJournal!
Co-Editor-in-Chief, Raoul Orvieto
Raoul Orvieto is a full professor of Obstetrics and Gynecology and incumbent of the Tarnesby-Tarnowski Chair for Family Planning and Fertility Regulation, at the Sackler Faculty of Medicine, Tel-Aviv University, Israel. Prof Orvieto is the director of the Division of Reproductive Endocrinology and Infertility, at the Sheba (Tel-Hashomer) Medical Center, Israel. He has been author and co-author of more than 200 publications in national and international journals. His scientific interests include various aspects of controlled ovarian hyperstimulation (COH). The role of GnRH-analogues, and specifically GnRH agonist versus antagonist in COH for IVF, pre-implantation genetic screening (PGS), triggering final follicular maturation and several aspects of ovarian hyperstimulation syndrome (OHSS): pathophysiology, prediction, prevention and its relation to the inflammatory response.
Co-Editor-in-Chief, David B Seifer
David B. Seifer is a Professor of Obstetrics & Gynecology at Yale School of Medicine in the Division of Reproductive Endocrinology and Infertility at Yale New Haven Hospital Medical Center in New Haven, CT (USA). Dr. Seifer is a consultant for the Food and Drug Administration (USA) and has published over 150 medical studies in peer-reviewed journals.
His translational research has focused upon the biology of ovarian function, particularly the aging ovary. This research has resulted in a better understanding of normal and abnormal follicular development during ART and in identifying novel human ovarian growth factors (ie. neurotrophins, inhibin B and AMH) which inform the clinical practice of reproductive medicine. His clinical research has focused upon health care disparities among women with infertility and the role of vitamin D in female reproductive health and polycystic ovarian syndrome.
'On Health' blog
08 September 2020
Annual Journal Metrics
47 days to first decision for reviewed manuscripts only
30 days to first decision for all manuscripts
120 days from submission to acceptance
16 days from acceptance to publication
3.235 - 2-year Impact Factor
3.582 - 5-year Impact Factor
1.222 - Source Normalized Impact per Paper (SNIP)
1.065 - SCImago Journal Rank (SJR)
163 Altmetric mentions